Immunochemotherapy Against Colon Cancer by Gene Transfer of Interleukin-12 in Combination With Oxaliplatin

OncoImmunology - United States
doi 10.4161/onci.1.1.17930
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Genetic Heterogeneity in the Toxicity to Systemic Adenoviral Gene Transfer of Interleukin-12

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2001English

Enhanced Antitumor Activity of Cerulenin Combined With Oxaliplatin in Human Colon Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

Dragon (RGMb) Induces Oxaliplatin Resistance in Colon Cancer Cells

Oncotarget
Oncology
2016English

Severe Anaphylaxis With Oxaliplatin Therapy in a Patient With Colon Cancer: A Case Report

Journal of Pharmaceutical Research
2015English

Interleukin-12 in Patients With Cancer Is Synthesized by Peripheral Helper T�lymphocytes

Oncology Letters
Cancer ResearchOncology
2015English

Colon Cancer Cells Gene Expression Signature as Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment

Frontiers in Pharmacology
Pharmacology
2016English

Interleukin 12 Gene Polymorphisms Enhance Gastric Cancer Risk in H Pylori Infected Individuals

Journal of Medical Genetics
Genetics
2005English

Liver Metastatic Model of Human Colon Cancer Constructed by Orthotopic Onplantation. A Suitable Model for Experimental Immunochemotherapy.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1994English

lncRNA KCNQ1OT1 Enhances the Chemoresistance of Oxaliplatin in Colon Cancer by Targeting the miR-34a/ATG4B Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy